- Home
- ADN vs PRPO Comparison
ADN vs PRPO Comparison
Compare ADN & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- PRPO
- Stock Information
- Founded
- ADN 2006
- PRPO N/A
- Country
- ADN United States
- PRPO United States
- Employees
- ADN N/A
- PRPO N/A
- Industry
- ADN Power Generation
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- ADN Utilities
- PRPO Industrials
- Exchange
- ADN Nasdaq
- PRPO Nasdaq
- Market Cap
- ADN 8.5M
- PRPO 9.6M
- IPO Year
- ADN N/A
- PRPO N/A
- Fundamental
- Price
- ADN $1.82
- PRPO $6.70
- Analyst Decision
- ADN
- PRPO
- Analyst Count
- ADN 0
- PRPO 0
- Target Price
- ADN N/A
- PRPO N/A
- AVG Volume (30 Days)
- ADN 28.4K
- PRPO 7.7K
- Earning Date
- ADN 10-15-2024
- PRPO 11-11-2024
- Dividend Yield
- ADN N/A
- PRPO N/A
- EPS Growth
- ADN N/A
- PRPO N/A
- EPS
- ADN N/A
- PRPO N/A
- Revenue
- ADN $7,026,000.00
- PRPO $16,719,999.00
- Revenue This Year
- ADN $2,232.99
- PRPO $75.18
- Revenue Next Year
- ADN $91.56
- PRPO N/A
- P/E Ratio
- ADN N/A
- PRPO N/A
- Revenue Growth
- ADN 9.01
- PRPO 52.61
- 52 Week Low
- ADN $1.71
- PRPO $4.31
- 52 Week High
- ADN $18.90
- PRPO $8.99
- Technical
- Relative Strength Index (RSI)
- ADN 41.18
- PRPO 52.82
- Support Level
- ADN $1.79
- PRPO $6.42
- Resistance Level
- ADN $2.17
- PRPO $6.99
- Average True Range (ATR)
- ADN 0.16
- PRPO 0.33
- MACD
- ADN 0.02
- PRPO -0.04
- Stochastic Oscillator
- ADN 23.91
- PRPO 69.91
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.